4.5 Article

Identification of novel molecular markers through transcriptomic analysis in human fetal and adult corneal endothelial cells

Journal

HUMAN MOLECULAR GENETICS
Volume 22, Issue 7, Pages 1271-1279

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/hmg/dds527

Keywords

-

Funding

  1. NIH [GM081621]
  2. International Science & Technology Cooperation Program of China [2011DFB30010]
  3. Ministry of Science and Technology 973 Basic Research program in China [2011CB965102, 2011CB966204, 2012CB966303]
  4. National Natural Science Foundation of China [81271258]
  5. Chinese Scholarship Council (CSC) [2011626117]
  6. California Institute of Regenerative Medicine Training Grant [TG2-01169]

Ask authors/readers for more resources

The corneal endothelium is composed of a monolayer of corneal endothelial cells (CECs), which is essential for maintaining corneal transparency. To better characterize CECs in different developmental stages, we profiled mRNA transcriptomes in human fetal and adult corneal endothelium with the goal to identify novel molecular markers in these cells. By comparing CECs with 12 other tissue types, we identified 245 and 284 signature genes that are highly expressed in fetal and adult CECs, respectively. Functionally, these genes are enriched in pathways characteristic of CECs, including inorganic anion transmembrane transporter, extracellular matrix structural constituent and cyclin-dependent protein kinase inhibitor activity. Importantly, several of these genes are disease target genes in hereditary corneal dystrophies, consistent with their functional significance in CEC physiology. We also identified stage-specific markers associated with CEC development, such as specific members in the transforming growth factor beta and Wnt signaling pathways only expressed in fetal, but not in adult CECs. Lastly, by the immunohistochemistry of ocular tissues, we demonstrated the unique protein localization for Wnt5a, S100A4, S100A6 and IER3, the four novel markers for fetal and adult CECs. The identification of a new panel of stage-specific markers for CECs would be very useful for characterizing CECs derived from stem cells or ex vivo expansion for cell replacement therapy. GEO accession number: GSE41616.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available